Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Randomised, Double-blind, Placebo-controlled First in Human Study to Assess the Safety and Pharmacokinetics of KH-001 Besylate in Healthy Male Participants

NCT07868237 is registered in ClinicalTrials.gov with Kadence Bio as lead sponsor.

NCT NCT07868237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07868237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Randomised, Double-blind, Placebo-controlled First in Human Study to Assess the Safety and Pharmacokinetics of KH-001 Besylate in Healthy Male Participants
Lead sponsor
Kadence Bio
Phase
Phase 1
Overall status
Completed
Start date
November 14, 2023
Completion date
August 28, 2025
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy male volunteers